title: Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308).
abstract: Substitution at the ortho position of N-(3,4-dimethyl-5-isoxazolyl) benzenesulfonamide led to the identification of the biphenylsulfonamides as a novel series of endothelin-A (ETA) selective antagonists. Appropriate substitutions on the pendant phenyl ring led to improved binding as well as functional activity. A hydrophobic group such as isobutyl or isopropoxyl was found to be optimal at the 4'-position. Introduction of an amino group at the 2'-position also led to improved analogues. Combination of the optimal 4'-isobutyl substituent with the 2'-amino function afforded an analogue (20, BMS-187308) with improved ETA binding affinity and functional activity. Compound 20 also has good oral activity in inhibiting the pressor effect caused by an ET-1 infusion in rats. Doses of 10 and 30 micromol/kg iv 20 attenuated the pressor responses due to the administration of exogenous ET-1 to conscious monkeys, indicating that the compound inhibits the in vivo activity of endothelin-1 in nonhuman primates.
authors.affiliation: Departments of Chemistry, Cardiovascular Agents, Cardiovascular Biochemistry, and Pharmacology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000, USA. Murugesan@bms.com
authors.forename: N
authors.initials: N
authors.lastname: Murugesan
authors.forename: Z
authors.initials: Z
authors.lastname: Gu
authors.forename: P D
authors.initials: PD
authors.lastname: Stein
authors.forename: S
authors.initials: S
authors.lastname: Bisaha
authors.forename: S
authors.initials: S
authors.lastname: Spergel
authors.forename: R
authors.initials: R
authors.lastname: Girotra
authors.forename: V G
authors.initials: VG
authors.lastname: Lee
authors.forename: J
authors.initials: J
authors.lastname: Lloyd
authors.forename: R N
authors.initials: RN
authors.lastname: Misra
authors.forename: J
authors.initials: J
authors.lastname: Schmidt
authors.forename: A
authors.initials: A
authors.lastname: Mathur
authors.forename: L
authors.initials: L
authors.lastname: Stratton
authors.forename: Y F
authors.initials: YF
authors.lastname: Kelly
authors.forename: E
authors.initials: E
authors.lastname: Bird
authors.forename: T
authors.initials: T
authors.lastname: Waldron
authors.forename: E C
authors.initials: EC
authors.lastname: Liu
authors.forename: R
authors.initials: R
authors.lastname: Zhang
authors.forename: H
authors.initials: H
authors.lastname: Lee
authors.forename: R
authors.initials: R
authors.lastname: Serafino
authors.forename: B
authors.initials: B
authors.lastname: Abboa-Offei
authors.forename: P
authors.initials: P
authors.lastname: Mathers
authors.forename: M
authors.initials: M
authors.lastname: Giancarli
authors.forename: A A
authors.initials: AA
authors.lastname: Seymour
authors.forename: M L
authors.initials: ML
authors.lastname: Webb
authors.forename: J T
authors.initials: JT
authors.lastname: Hunt
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects; D002339:Carotid Arteries / Q000187:drug effects / Q000502:physiology; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1 / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007555:Isoxazoles / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D008252:Macaca fascicularis; D008297:Male; D011817:Rabbits; D011869:Radioligand Assay; D051381:Rats; D044022:Receptor, Endothelin A; D013329:Structure-Activity Relationship; D013449:Sulfonamides / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects
chemical_list: D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1; D007555:Isoxazoles; D044022:Receptor, Endothelin A; D013449:Sulfonamides; C116543:BMS 187308